[Objectives]To systematically evaluate the total clinical effective rate of acupuncture treatment of depression,and provide clinical reference for the scheme design and selection of acupuncture treatment of depression...[Objectives]To systematically evaluate the total clinical effective rate of acupuncture treatment of depression,and provide clinical reference for the scheme design and selection of acupuncture treatment of depression.[Methods]By searching CNKI,Wanfang Data,CBM,VIP,Cochrane Library,Cochrane Central,Springer and other databases,randomized controlled experiment(RCT)on acupuncture and moxibustion treatment of depression from January 1,2019 to August 31,2022 was collected,to extract relevant data of total clinical effective rate and conduct methodological quality evaluation.ReviewManager 5.4.1 software was used for Meta analysis.[Results]22 RCTs were included,1602 patients in total.Among them,there were 804 cases in treatment group and 798 cases in control group.Meta analysis results displayed that acupuncture and moxibustion treatment of depression may be better than the control group in improving the total clinical effective rate,and the difference was statistically significant[MD=1.16,95%CI(1.11,1.21)].[Conclusions]Acupuncture and moxibustion can achieve a higher total clinical effective rate in the treatment of depression,which is worthy of clinical application.However,due to fewer studies included in this systematic evaluation,small sample size,and low quality,there was a high possibility of bias.Therefore,the above conclusions needed to be verified by high-quality,large-sample,and multi-center RCTs.展开更多
In this paper,we study make-or-buy decisions with the consideration of retail-level competition,in which a supplier provides substitutable products to two retailers.One incumbent retailer is capable of producing the p...In this paper,we study make-or-buy decisions with the consideration of retail-level competition,in which a supplier provides substitutable products to two retailers.One incumbent retailer is capable of producing the product in-house and makes the make-or-buy decision,while the rival retailer can only outsource from the supplier.Intuitively,the incumbent will not outsource if the wholesale price is higher than its production cost.However,we illustrate this may not be true when the supplier also supplies the retail rival.In this case,the incumbent may accept a high wholesale price to limit the supplier's incentive to serve the retail rival on particularly favorable terms.Moreover,under certain circumstances,the supplier may charge a wholesale price lower than its production cost to attract orders from the incumbent,which can generate for the supplier and the incumbent a higher total profit than the situation in which the incumbent makes the product in-house.展开更多
基金Supported by Shiyan Guiding Project in 2021(21Y33).
文摘[Objectives]To systematically evaluate the total clinical effective rate of acupuncture treatment of depression,and provide clinical reference for the scheme design and selection of acupuncture treatment of depression.[Methods]By searching CNKI,Wanfang Data,CBM,VIP,Cochrane Library,Cochrane Central,Springer and other databases,randomized controlled experiment(RCT)on acupuncture and moxibustion treatment of depression from January 1,2019 to August 31,2022 was collected,to extract relevant data of total clinical effective rate and conduct methodological quality evaluation.ReviewManager 5.4.1 software was used for Meta analysis.[Results]22 RCTs were included,1602 patients in total.Among them,there were 804 cases in treatment group and 798 cases in control group.Meta analysis results displayed that acupuncture and moxibustion treatment of depression may be better than the control group in improving the total clinical effective rate,and the difference was statistically significant[MD=1.16,95%CI(1.11,1.21)].[Conclusions]Acupuncture and moxibustion can achieve a higher total clinical effective rate in the treatment of depression,which is worthy of clinical application.However,due to fewer studies included in this systematic evaluation,small sample size,and low quality,there was a high possibility of bias.Therefore,the above conclusions needed to be verified by high-quality,large-sample,and multi-center RCTs.
基金National Natural Science Foundation of China 71831007,71571079,71571160Social Science Foundation in Zhejiang Province 13ZJQN041YBby the Fundamental Research Funds for the Central Universities,No.2019kfyXMBZ046.
文摘In this paper,we study make-or-buy decisions with the consideration of retail-level competition,in which a supplier provides substitutable products to two retailers.One incumbent retailer is capable of producing the product in-house and makes the make-or-buy decision,while the rival retailer can only outsource from the supplier.Intuitively,the incumbent will not outsource if the wholesale price is higher than its production cost.However,we illustrate this may not be true when the supplier also supplies the retail rival.In this case,the incumbent may accept a high wholesale price to limit the supplier's incentive to serve the retail rival on particularly favorable terms.Moreover,under certain circumstances,the supplier may charge a wholesale price lower than its production cost to attract orders from the incumbent,which can generate for the supplier and the incumbent a higher total profit than the situation in which the incumbent makes the product in-house.
